Outcome of Board Meeting
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 17, 2013, has discussed and approved the following:1. The Business Transfer Agreement (BTA) with Hospira has been extended till June 30, 2013, Consequently, the Board approved the extension of financial year 2012-2013 of the Company by a period of 3 (three) months i.e. up to June 30, 2013. Accordingly, the Annual... Updates
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that Orchids Cephalosporin API manufacturing complex located in Alathur, Chennai has successfully cleared the USFDA inspection that it went through. The facility manufactures a range of oral and sterile Cephalosporin APIs and caters to the developed markets like USA, Europe and Japan. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
R Vijaylakshmi & Orchid Healtcare Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Orchid Chemicals & Pharmaceuticals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
R Vijayalakshmi has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Financial Results with Results Press Release & Limited Review for Dec 31, 2012
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE about the Financial Results, Results Press Release & a copy of the Limited Review Report for the period ended December 31, 2012. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
K Raghavendra Rao, R Vijayalakshmi & Orchid Health Care Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
K Raghavendra Rao & Orchid Health Care Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
R Vijayalakshmi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE